antibody sell week action yearonyear industry streak today group requests therapy protection cent supplying patients status price brand sources bank import billion reddys notice pharma state tax days bench points

Articles for Cipla, search results for global

Weight-loss drugs: A game changer for India’s top pharma companies
1 day, 23 hours ago

Weight-loss drugs: A game changer for India’s top pharma companies

Live Mint  

Over 650 million adults globally suffer from obesity, and this number is only expected to rise. India’s rising players in the GLP-1 market Indian pharmaceutical giants like Sun Pharma, Cipla, Dr. Reddy’s, Natco Pharma, and Lupin are in a fierce race to bring obesity drugs to the Indian market. Cipla: Entering the market with generics Cipla, one of India’s most …

India Weight Loss Loss Indian Obesity Companies Weight
Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Sept 30
2 months, 3 weeks ago

Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Sept 30

Live Mint  

Buy or sell stocks: Despite global market sentiments, the Indian stock market snapped a six-session winning streak on Friday. Sumeet Bagadia's stocks to buy today Sumeet Bagadia, Executive Director at Choice Broking, believes the overall trend of the Indian stock market is bullish, and the Nifty 50 index is poised to touch 26,900 despite the 50-stock index closing red on …

Positive Index Stock Nifty Stop Target Buy
Stocks to Watch: AU Small Finance Bank, GIC, Zee, Cipla, SpiceJet, KIMS, and more
3 months, 3 weeks ago

Stocks to Watch: AU Small Finance Bank, GIC, Zee, Cipla, SpiceJet, KIMS, and more

Live Mint  

Here’s a quick look at stocks likely to be in focus in today's trade. AU Small Finance Bank: On Tuesday, WestBridge Capital divested a 1.5 percent stake in AU Small Finance Bank, amounting to ₹736 crore through open market transactions. As per BSE's bulk deal data, WestBridge Capital, via its affiliate WestBridge AIF I, sold 1,08,95,517 shares at an average …

Bank Zee Shares Cipla Spicejet Kims Small Finance Bank
Torrent Pharmaceutical said to be in talks with Apollo to borrow up to $1 bn for Cipla bid
1 year, 3 months ago

Torrent Pharmaceutical said to be in talks with Apollo to borrow up to $1 bn for Cipla bid

The Hindu  

Torrent Pharmaceutical is in preliminary talks with Apollo Global Management to secure a loan of up to $1 billion to help fund a planned bid for Cipla, two people briefed on the discussions said. Torrent has also been in talks with CVC Capital Partners and Bain Capital who might become equity partners in a consortium and contribute as much as …

India Talks Billion Cipla Apollo Torrent
Torrent in talks with Apollo to borrow up to $1 bn for Cipla bid: Report
1 year, 3 months ago

Torrent in talks with Apollo to borrow up to $1 bn for Cipla bid: Report

Live Mint  

India's Torrent Pharmaceutical is in preliminary talks with Apollo Global Management to secure a loan of up to $1 billion to help fund a planned bid for Cipla, two people briefed on the discussions said. Torrent has also been in talks with CVC Capital Partners and Bain Capital who might become equity partners in a consortium and contribute as much …

India Talks Billion Cipla Apollo Torrent
Stocks to Watch: Tata Motors, Cipla, Infosys, Zee Ent, Vedanta, Sun Pharma, and Others
1 year, 3 months ago

Stocks to Watch: Tata Motors, Cipla, Infosys, Zee Ent, Vedanta, Sun Pharma, and Others

News 18  

Stocks to Watch on September 15: GIFT Nifty on the NSE IX traded 11.5 points, or 0.06 per cent, higher at 20,229, signaling that Dalal Street was headed for positive start on Friday. Sun Pharma: LIC on Thursday said it has sold 2 per cent of its holding in Sun Pharma for Rs 4,699 crore via open market sale. Vedanta …

Indian Pharma Cent Ent Vedanta Tata Motors Sun Pharma
Here's why Cipla shares fell nearly 7% today
1 year, 10 months ago

Here's why Cipla shares fell nearly 7% today

India Today  

Shares of pharma giant Cipla fell 7 per cent during intraday trade on Monday, but recovered marginally to settle slightly higher. The company’s stock was the second biggest loser on the NSE Nifty 50 today, down 6.12 per cent at closing. The sharp fall in Cipla’s stock came after the company said that the United States Food and Drug Administration …

Company Cipla Usfda Today Shares
Cipla’s Yusuf K Hamied is India’s medicine man
3 years, 10 months ago

Cipla’s Yusuf K Hamied is India’s medicine man

Live Mint  

Sitting at his home in Marbella in southern Spain, Yusuf K. Hamied, the 84-year-old chairman of Cipla, one of India’s oldest pharmaceutical companies and a global pharma behemoth, recalls the exact moment when he realised the covid-19 pandemic was serious. Even today, I might spend four-five hours reading on newer drugs, what’s coming out, what’s not coming out, what can …

Global India Family Planning Drugs Industry Indian Man
Cipla confirms collaboration with CSIR, IICT, ICMR to develop COVID-19 treatment
4 years, 4 months ago

Cipla confirms collaboration with CSIR, IICT, ICMR to develop COVID-19 treatment

Firstpost  

The Mumbai-based firm is also ramping up manufacturing of drugs required to treat COVID-19, like Lopinavir-Ritonavir and Hydroxychloroquine Drug major Cipla is working with government agencies to develop a treatment for COVID-19, while ramping up the production of various life saving essential drugs, according to company’s chairman YK Hamied. Besides scaling up production of medicines that show potency against the …

Company Develop Cipla Essential Drugs Drugs Hamied
Cipla launches generic remdesivir for COVID-19 patients
4 years, 6 months ago

Cipla launches generic remdesivir for COVID-19 patients

India TV News  

Homegrown pharma major Cipla Ltd announced the launch of its generic version of remdesivir, which has been authorised for emergency use in the treatment of COVID-19 patients by the USFDA, under its brand name Cipremi. The USFDA had issued an Emergency Use Authorization to Gilead Sciences Inc for emergency use of remdesivir for the treatment of COVID-19 patients. Remdesivir is …

India Treatment Patients Cipla Usfda Emergency Use Remdesivir